These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 18758186

  • 1. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group.
    Tanaka H, Oki E, Tsuruga K, Sato N, Matsukura H, Matsunaga A, Kondo Y, Suzuki J.
    Nephron Clin Pract; 2008; 110(2):c73-9. PubMed ID: 18758186
    [Abstract] [Full Text] [Related]

  • 2. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H, Tsugawa K, Suzuki K, Nakahata T, Ito E.
    Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
    [Abstract] [Full Text] [Related]

  • 3. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
    Tanaka H, Watanabe S, Aizawa-Yashiro T, Oki E, Kumagai N, Tsuruga K, Ito E.
    Nephron Clin Pract; 2012 Jul; 121(3-4):c165-73. PubMed ID: 23327881
    [Abstract] [Full Text] [Related]

  • 4. Mizoribine for the treatment of lupus nephritis in children and adolescents.
    Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S.
    Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
    [Abstract] [Full Text] [Related]

  • 5. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.
    Tanaka H, Oki E, Tsuruga K, Yashiro T, Hanada I, Ito E.
    Clin Nephrol; 2009 Dec; 72(6):430-6. PubMed ID: 19954719
    [Abstract] [Full Text] [Related]

  • 6. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
    Tanaka H, Tsugawa K, Nakahata T, Kudo M, Suzuki K, Ito E.
    Clin Nephrol; 2005 Jun; 63(6):417-22. PubMed ID: 15960142
    [Abstract] [Full Text] [Related]

  • 7. Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients.
    Tanaka H, Tsugawa K, Oki E, Suzuki K, Ito E.
    Clin Rheumatol; 2008 Jan; 27(1):85-9. PubMed ID: 17483980
    [Abstract] [Full Text] [Related]

  • 8. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study.
    Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E.
    Lupus; 2007 Jan; 16(11):896-900. PubMed ID: 17971363
    [Abstract] [Full Text] [Related]

  • 9. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis.
    Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Ito E, Waga S.
    Clin Nephrol; 2003 Dec; 60(6):390-4. PubMed ID: 14690255
    [Abstract] [Full Text] [Related]

  • 10. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H.
    Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
    [Abstract] [Full Text] [Related]

  • 11. Long-term intermittent pulse therapy with mizoribine attenuates histologic progression in young patients with severe lupus nephritis: report of two patients.
    Tanaka H, Oki ES, Tsugawa K, Suzuki K, Tsuruga K, Ito E.
    Nephrology (Carlton); 2007 Aug; 12(4):376-9. PubMed ID: 17635753
    [Abstract] [Full Text] [Related]

  • 12. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
    Feng X, Gu F, Chen W, Liu Y, Wei H, Liu L, Yin S, Da Z, Sun L.
    Chin Med J (Engl); 2014 Aug; 127(21):3718-23. PubMed ID: 25382325
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of mizoribine in the treatment of systemic lupus erythematosus in children.
    Yoshidome K, Takei S, Imanaka H, Maeno N, Ohkawa T, Kawano Y.
    Pediatr Int; 2004 Aug; 46(4):444-9. PubMed ID: 15310311
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis.
    Tanaka H, Aizawa T, Watanabe S, Oki E, Tsuruga K, Imaizumi T.
    Lupus; 2014 Jul; 23(8):813-8. PubMed ID: 24651669
    [Abstract] [Full Text] [Related]

  • 15. Mizoribine therapy for patients with lupus nephritis: the association between peak mizoribine concentration and clinical efficacy.
    Kuroda T, Hirose S, Tanabe N, Sato H, Nakatsue T, Ajiro J, Wada Y, Murakami S, Hasegawa H, Ito S, Sakatsume M, Nakano M, Gejyo F.
    Mod Rheumatol; 2007 Jul; 17(3):206-12. PubMed ID: 17564775
    [Abstract] [Full Text] [Related]

  • 16. Usefulness and safety of high-dose mizoribine on ABO-incompatible living related kidney transplantation using anti-CD20 and anti-CD25 antibodies without splenectomy: 3-year results.
    Yoshimura N, Ushigome H, Nobori S, Suzuki T, Sakai K, Koshino K, Nakamura T, Nakao T, Harada S, Ito T.
    Transplant Proc; 2014 Jul; 46(2):391-4. PubMed ID: 24655971
    [Abstract] [Full Text] [Related]

  • 17. A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.
    Tsubouchi Y, Fukuda W, Kawahito Y, Kohno M, Wada M, Ishino H, Hamaguchi M, Yamamoto A, Kadoya M, Niimi M, Yoshikawa T.
    Mod Rheumatol; 2008 Jul; 18(1):91-5. PubMed ID: 18159569
    [Abstract] [Full Text] [Related]

  • 18. Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome.
    Tanaka H, Tsugawa K, Nakahata T, Kudo M, Onuma S, Kimura S, Ito E.
    Tohoku J Exp Med; 2005 Jan; 205(1):87-91. PubMed ID: 15635277
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome of tacrolimus-based immunosuppressive treatment for patients with paediatric-onset lupus nephritis.
    Tanaka H, Aizawa T, Endo M.
    Nephrology (Carlton); 2024 Oct 21. PubMed ID: 39429105
    [Abstract] [Full Text] [Related]

  • 20. Excellent results of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids in renal transplant recipients--4-year results.
    Yoshimura N, Ushigome H, Nobori S, Suzuki T, Sakai K, Koshino K, Okajima H, Okamoto M.
    Transplant Proc; 2013 May 21; 45(4):1472-5. PubMed ID: 23726600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.